Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyotoshi Imai

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Biomarker Research|March 22, 2014
Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinibNaoto Takahashi, Masatomo Miura, Jun Kuroki, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 8, 2018
Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net StudyDaisuke Hidaka, Masahiro Onozawa, Junichi Hashiguchi, et al.
International Journal of Hematology|September 21, 2017
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 studyNaoto Takahashi, Tetsuzo Tauchi, Kunio Kitamura, et al.
Leukemia & Lymphoma|November 1, 2012
Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromesYasunori Ueda, Chisato Mizutani, Yasuhito Nannya, et al.
International Journal of Hematology|October 14, 2017
Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemiaYachiyo Kuwatsuka, Daisuke Tomizawa, Rika Kihara, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Biomarker Research|March 22, 2014
Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinibNaoto Takahashi, Masatomo Miura, Jun Kuroki, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 8, 2018
Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net StudyDaisuke Hidaka, Masahiro Onozawa, Junichi Hashiguchi, et al.
International Journal of Hematology|September 21, 2017
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 studyNaoto Takahashi, Tetsuzo Tauchi, Kunio Kitamura, et al.
Leukemia & Lymphoma|November 1, 2012
Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromesYasunori Ueda, Chisato Mizutani, Yasuhito Nannya, et al.
International Journal of Hematology|October 14, 2017
Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemiaYachiyo Kuwatsuka, Daisuke Tomizawa, Rika Kihara, et al.
Pageof 3